Hadassah

Pro-Tumor White Blood Cells Discovered at Hadassah

Tuesday, Feb 3 2015

Researchers at the Hadassah Medical Organization and Hebrew University have found that the most common form of white blood cells, called neutrophils, contain at least three distinct subtypes. Some fight the development of cancer, while others provide a hospitable environment for their growth.

The research findings could lead to new cancer-fighting therapies that seek to boost the anti-tumor neutrophils while limiting the proliferation of pro-tumor neutrophils.

In the last decade new approaches to cancer have involved activating the patient’s immune system against cancer cells, while not harming nearby healthy cells. Recently, however, researchers have discovered that there are healthy cells which surround the tumor that play an important role in enhancing cancer development. Thus, while neutrophils, which comprise between 50-70 percent of all white blood cells, are traditionally associated with fighting infections, accumulating data suggest they also play an important role in tumor biology. The Hadassah-Hebrew University scientists, working with mouse tumors and human blood samples, found that in early stages of the disease, tumor-limiting neutrophils prevail, but as cancer progresses, the tumor-promoting neutrophil subpopulation becomes dominant. As the authors explain:

“We identified a heterogeneous subset of low-density neutrophils (LDNs) that appear transiently in self-resolving inflammation, but accumulate continuously with cancer progression. LDNs display impaired neutrophil function and immunosuppressive properties, characteristics that are in stark contrast to those of mature, high-density neutrophils (HDNs). Proper understanding of the effect of tumors on neutrophils, as well as the way these cells support or fight cancer, could help us develop strategies to direct the immune system against the tumor, and potentially improve cancer treatment in general and immunotherapy in particular."

The research study, led by Dr. Zvi Fridlender, at the Hadassah-Hebrew University Medical Center’s Institute of Pulmonary Medicine, and Dr. Zvika Granot, at the Hebrew University’s Institute for Medical Research Israel-Canada (IMRIC) in the Faculty of Medicine, is highlighted in "Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer" in the January 22, 2015 on-line issue of Cell Reports.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, May 23 2017

First Ladies Melania Trump and Sara Netanyahu Visit Hadassah Hospital

Please share our pride in Hadassah Hospital, singled out by the Israeli government to showcase the nation’s top-quality medicine, top doctors, and innovative medical research. First Lady Melania Trump and First Lady Sara Netanyahu visited Hadassah Hospital Ein Kerem on May 22...

READ MORE ›
alt_text

Wednesday, May 10 2017

Hadassah’s Melanoma Maven Featured in Hadassah Magazine

Metastatic melanoma is typically fatal, but Hadassah Hospital’s Prof. Michal Lotem, a world-renowned, cutting-edge physician/scientist, is trailblazing new treatments that are being watched around the globe.

READ MORE ›
alt_text

Monday, May 1 2017

Hadassah Surgeon to Light Torch at Jerusalem Independence Day Ceremony

Meet Prof. Ahmed Eid of Hadassah Hospital, who will light the torch at Jerusalem's Independence Day Ceremony, in honor of the city’s doctors who tirelessly work to save lives and improve the quality of life of men, women and children.

READ MORE ›

Friday, Apr 28 2017

Surgeons Perform World’s First-Ever Dual Robotic Surgery
 at Jerusalem’s Hadassah Hospital

The world’s first-of-its-kind dual robotic surgery was performed on April 23 at Hadassah Hospital Ein Kerem in Jerusalem, announced National President Ellen Hershkin of Hadassah, the Women’s Zionist Organization of America, Inc. (HWZOA).

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More